Secondary cost-effectiveness analysis of the STEADI Options telemedicine fall-prevention trial in adults aged 65+ at raised fall risk: incremental net benefit $1995 per enrollee, cost-effective in 82.9% of simulations, but cost and fall differences were not significant.
RCT
Rein et al. The cost-effectiveness of the stopping elderly accidents, deaths and injuries options randomised quality improvement trial to prevent falls among older adults